Injection Pen Market Growth & Trends
The global injection pen market size is expected to reach USD 60.7 billion by 2030, according to a new report by Grand View Research, Inc., registering a 7.4% from 2025 to 2030. High demand for these devices for management of various chronic as well as acute diseases and increasing awareness in developing regions are key factors expected to drive the market.
Injectable pens have witnessed significant success in improving patient convenience during management of chronic disease, a process that might include administering intermittent injections. These devices are more convenient and affordable than other delivery systems. Ongoing studies on the same to assess their applications in management of other diseases, including but not limited to Hepatitis C and cancer, is expected to ensure swift market growth through 2025.
Injection Pen Market Report Highlights
- The reusable segment accounted for the largest revenue share of 70.4% in 2024 and is expected to grow at the fastest CAGR over the forecast period due to the growing focus on environmental sustainability in the healthcare industry.
- The hospital segment dominated the market with the largest revenue share of 39.4% in 2024, due to the quick acceptance and boost from the rise in government efforts to enhance healthcare infrastructure and the increasing population of diabetes patients within the evaluated timeframe.
- North America dominated the injection pen market and accounted for a 44.7% share in 2024. The rising occurrence of non-communicable diseases, such as diabetes, cancer, cardiovascular conditions, and multiple sclerosis in countries like Canada and the U.S. is a major factor driving the growth of the market.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1. Segment Definitions
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End Use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecasts timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End Use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
- Chapter 3. Injection Pen Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Injection Pen Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- Chapter 4. Injection Pen Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Injection Pen Market: Product Movement Analysis
- 4.3. Injection Pen Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Disposable
- 4.5.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Reusable
- 4.6.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Injection Pen Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Injection Pen Market: Application Movement Analysis
- 5.3. Injection Pen Market by Application Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Diabetes
- 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Anaphylaxis
- 5.6.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Osteoporosis
- 5.7.1. Osteoporosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Growth Hormone Deficiency
- 5.8.1. Growth Hormone Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9. Arthritis
- 5.9.1. Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.10. Others
- 5.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Injection Pen Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Injection Pen Market: End Use Movement Analysis
- 6.3. Injection Pen Market by End Use Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Hospital
- 6.5.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Clinics
- 6.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Home Care Settings
- 6.7.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 7. Injection Pen Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional Injection Pen Market movement analysis
- 7.3. Injection Pen Market: Regional Estimates & Trend Analysis by Technology & Usability
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. North America
- 7.5.1. North America Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. U.S. Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Canada Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. Mexico Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Europe
- 7.5.6. Europe Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. UK
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Reimbursement scenario
- 7.5.7.5. UK Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Germany
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Competitive Scenario
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Reimbursement scenario
- 7.5.8.5. Germany Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. France
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Competitive Scenario
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Reimbursement scenario
- 7.5.9.5. France Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.10. Italy
- 7.5.10.1. Key Country Dynamics
- 7.5.10.2. Competitive Scenario
- 7.5.10.3. Regulatory Framework
- 7.5.10.4. Reimbursement scenario
- 7.5.10.5. Italy Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.11. Spain
- 7.5.11.1. Key Country Dynamics
- 7.5.11.2. Competitive Scenario
- 7.5.11.3. Regulatory Framework
- 7.5.11.4. Reimbursement scenario
- 7.5.11.5. Spain Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.12. Denmark
- 7.5.12.1. Key Country Dynamics
- 7.5.12.2. Competitive Scenario
- 7.5.12.3. Regulatory Framework
- 7.5.12.4. Reimbursement scenario
- 7.5.12.5. Denmark Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.13. Sweden
- 7.5.13.1. Key Country Dynamics
- 7.5.13.2. Competitive Scenario
- 7.5.13.3. Regulatory Framework
- 7.5.13.4. Reimbursement scenario
- 7.5.13.5. Sweden Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.14. Norway
- 7.5.14.1. Key Country Dynamics
- 7.5.14.2. Competitive Scenario
- 7.5.14.3. Regulatory Framework
- 7.5.14.4. Reimbursement scenario
- 7.5.14.5. Norway Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Japan Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. China Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement scenario
- 7.6.4.5. India Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement scenario
- 7.6.5.5. South Korea Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement scenario
- 7.6.6.5. Australia Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement scenario
- 7.6.7.5. Thailand Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Brazil Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. Argentina Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Middle East & Africa
- 7.8.1. Middle East & Africa Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. South Africa Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. Saudi Arabia Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement scenario
- 7.8.4.5. UAE Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Reimbursement scenario
- 7.8.5.5. Kuwait Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. BD
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Type benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Eli Lilly and Company
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Type benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Ypsomed AG
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Type benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Biocon
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Type benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Pfizer Inc.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Type benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Novartis AG
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Type benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Novo Nordisk A/S
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Type benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Sanofi
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Type benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Owen Mumford Ltd.
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Type benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Merck KGaA
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Type benchmarking
- 8.2.10.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook